0001493152-24-015812.txt : 20240424
0001493152-24-015812.hdr.sgml : 20240424
20240424170026
ACCESSION NUMBER: 0001493152-24-015812
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240422
FILED AS OF DATE: 20240424
DATE AS OF CHANGE: 20240424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tapolczay David
CENTRAL INDEX KEY: 0001991789
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41245
FILM NUMBER: 24871366
MAIL ADDRESS:
STREET 1: 32 CROUCH HALL LANE
CITY: ST. ALBANS
STATE: X0
ZIP: AL3 7EU
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONDUIT PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001896212
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 873272543
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4995 MURPHY CANYON ROAD, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
BUSINESS PHONE: (760) 471 8536
MAIL ADDRESS:
STREET 1: 4995 MURPHY CANYON ROAD, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
FORMER COMPANY:
FORMER CONFORMED NAME: Murphy Canyon Acquisition Corp.
DATE OF NAME CHANGE: 20211130
4
1
ownership.xml
X0508
4
2024-04-22
0
0001896212
CONDUIT PHARMACEUTICALS INC.
CDT
0001991789
Tapolczay David
4995 MURPHY CANYON ROAD, SUITE 300
SAN DIEGO
CA
92123
1
1
0
0
Chief Executive Officer
0
Warrant (Right to buy)
3.12
2024-04-22
4
A
0
400664
A
2025-04-22
2027-04-22
Common Stock
400664
400664
D
Warrant (Right to buy)
3.12
2024-04-22
4
S
0
200332
D
2025-04-22
2027-04-22
Common Stock
200332
200332
D
Warrants issued in exchange for one year lock-up of reporting person's common stock of the company, par value $0.0001 per share, and the payment of $0.125 per warrant.
Warrants sold in exchange for $0.25 per warrant in private transaction.
/s/ David Tapolczay
2024-04-24